{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:23:28Z","timestamp":1778750608081,"version":"3.51.4"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1097\/ms9.0000000000004372","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T11:00:16Z","timestamp":1763118016000},"page":"1023-1024","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["CAR T-cell therapy in pediatric acute lymphoblastic leukemia a new paradigm"],"prefix":"10.1097","volume":"88","author":[{"given":"Asra","family":"Amjad","sequence":"first","affiliation":[{"name":"Department of Medicine, Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mir Raza","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Postgraduate Medical Centre Karachi, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0717-2777","authenticated-orcid":false,"given":"Muddassir","family":"Khalid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Nishtar Medical University, Multan, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"R1-20260514","doi-asserted-by":"crossref","first-page":"439\u201348","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-Cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N Engl J Med"},{"key":"R2-20260514","doi-asserted-by":"crossref","first-page":"1396490","DOI":"10.3389\/fonc.2024.1396490","article-title":"Mechanisms and management of CAR T toxicity","volume":"14","author":"Ferreri","year":"2024","journal-title":"Front Oncol"},{"key":"R3-20260514","first-page":"JCO2200642","article-title":"Three-year update of tisagenlecleucel in pediatric and young adult patients with relapsed\/Refractory acute lymphoblastic leukemia in the ELIANA trial","volume":"41","author":"Laetsch","year":"2022","journal-title":"J Clin Oncol"},{"key":"R4-20260514","doi-asserted-by":"crossref","first-page":"625\u201338","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R5-20260514","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-025-02334-6","article-title":"Strategies to overcome tumour relapse caused by antigen escape after CAR T therapy","volume":"24","author":"Lu","year":"2025","journal-title":"Mol Cancer"},{"key":"R6-20260514","doi-asserted-by":"crossref","first-page":"1797\u2013805","DOI":"10.1038\/s41591-021-01497-1","article-title":"CAR T\u2009cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B\u2009cell acute lymphoblastic leukemia: a phase 1 trial","volume":"27","author":"Cordoba","year":"2021","journal-title":"Nat Med"},{"key":"R7-20260514","doi-asserted-by":"crossref","first-page":"1433432","DOI":"10.3389\/fonc.2024.1433432","article-title":"\u201cOff-The-Shelf\u201d allogeneic chimeric antigen receptor T-cell therapy for B-cell malignancies: current clinical evidence and challenges","volume":"14","author":"Mohty","year":"2024","journal-title":"Front Oncol"},{"key":"R8-20260514","doi-asserted-by":"crossref","first-page":"e009611","DOI":"10.1136\/jitc-2024-009611","article-title":"CAR-T cell therapy in developing countries: how long should we wait?","volume":"12","author":"Gautam","year":"2024","journal-title":"J Immunother Cancer"},{"key":"R9-20260514","first-page":"100082","article-title":"Transparency in the reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T09:03:40Z","timestamp":1778749420000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000004372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004372","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"2025-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}